Stéphane Cook

Long-term follow-up of an extreme kinking of a right coronary artery stenosis treated with a bioresorbable vascular scaffold

Stierlin F, Puricel S, Cook S

October 4, 2019 | 10.4244/EIJ-D-18-00441

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne RA, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Switzerland: coronary and structural heart interventions from 2010 to 2015

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Rothlisberger C, Corti R, Rickli H, Kaiser C, Roffi M

May 15, 2017 | 10.4244/EIJ-D-16-00828

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery disease

Cook S, Nef H, Capodanno D, Tamburino C, Baumbach A

August 20, 2016 | 10.4244/EIJV12I6A130

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

Franzone A, Taniwaki M, Rigamonti F, Heg D, Piccolo R, Roffi M, Tüller D, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T

August 5, 2016 | 10.4244/EIJV12I5A99

A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)

Puricel S, Arroyo D, Goy J-J, Praz F, Palhais N, Wahl A, Stauffer J-C, Togni M, Berger A, Meier B, Cook S

June 19, 2015 | 10.4244/EIJY14M05_05

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S

March 20, 2015 | 10.4244/EIJY15M01_04

Long-term comparison of everolimus-eluting and biolimus-eluting stents

Puricel S, Oberhänsli M, Guntern P, Lehmann S, Goy J-J, Arroyo D, Villeneuve H, Baeriswyl G, Stauffer J-C, Togni M, Cook S

July 26, 2013 | 10.4244/EIJV9I3A55

A modified technique of balloon anchoring for tricky stent delivery

Aeby G, Surmely J-F, Togni M, Cook S

January 18, 2013 | 10.4244/EIJV8I9A168

Sealing pseudo-aneurysms of the femoral artery with saline injection: a new technique

Périard D, Meyer M-A, Hayoz D, Cook S

February 21, 2012 | 10.4244/EIJV7I10A192

Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study

Puricel S, Adorjan P, Oberhänsli M, Stauffer J-C, Moschovitis A, Vogel R, Goy J-J, Muller O, Eeckhout E, Togni M, Wenaweser P, Meier B, Windecker S, Cook S

October 28, 2011 | 10.4244/EIJV7I6A112

Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study

Eshtehardi P, Cook S, Wandel S, Räber L, Wenaweser P, Togni M, Vogel R, Garachemani A, Eberli F, Lüscher T, Jüni P, Hess O, Meier B, Windecker S

September 30, 2010

Percutaneous coronary interventions in Europe in 2006

Moschovitis A, Cook S, Meier B

June 30, 2010 | 10.4244/EIJV7I6A31

Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year

Barragan P, Fajadet J, Sheiban I, Serruys P, Colombo A, Seabra-Gomes R, Goy J-J, Cook S, Rubino P, Lefèvre T

August 20, 2008

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-González I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys P

May 13, 2008

Have we been misled by the ESC DES firestorm?

Cook S, Meier B

March 20, 2008

Percutaneous coronary interventions in Europe in 2005

Praz L, Cook S, Meier B

January 20, 2008

Percutaneous coronary interventions in Europe 1992-2003

Cook S, Togni M, Walpoth N, Maier W, Muehlberger V, Legrand V, Milicic D, Zambartas C, Zelízko M, Madsen J-K, van Buuren F, López-Palop R, Peeba M, Koskenkorva J, Vanhanen H, Lablanche J, Lazaris I, Géza F, Eyjolfsson K, Kearney P, Piscione F, Erglis A, Navickas R, Beissel J, Channam R, Koch K, Deleanu D, Melberg T, Witkowski A, Pereira H, Reho I, Fridrich V, Zorman D, Nilsson T, Oezmen F, Ludman P, Meier B

February 20, 2006

Stéphane Cook

Latest news